Retrospective study reports favorable survival outcomes in elderly lung cancer patients, highlighting careful patient selection.
With the progressive aging of society, the incidence of lung cancer among elderly patients is increasing. However, surgical outcomes in patients aged ≥85 years remain unclear. We retrospectively reviewed 2,449 patients who underwent pulmonary resection for primary lung cancer at our institution between 2009 and 2023. Of these, 77 (3.1%) were aged ≥85 years. Clinical characteristics, perioperative complications, overall survival (OS), disease-specific survival (DSS), and follow-up status were analyzed as of April 2025. Patients who became unable to attend outpatient visits due to a decline in activities of daily living (ADL) were defined as “dropouts.” Perioperative complications occurred in 6.5%, including one perioperative death (1.3%) due to acute exacerbation of interstitial pneumonia. Short-term outcomes were favorable compared with previous reports, and long-term survival was not inferior. The 5-year OS rate was 43.9%, and the median survival time was 52 months. The 5-year DSS rate was 67.6%. At 5 years after surgery, 72.7% of patients had dropped out of follow-up due to death or functional decline, including deterioration of ADL.v Pulmonary resection can be safely performed in carefully selected patients aged ≥85 years. However, because approximately three-quarters became unable to continue follow-up within 5 years, careful preoperative explanation and informed consent are essential.
No takes yet. Share an insight, caveat, or question.
Mizukami et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: